The system involves one or two thin leads implanted under the skin, which deliver pulses of electricity to the nerves to block or reduce pain signals.
The FDA recently approved the 60-day device for a broader range of applications, including treatment in the head, neck and front of the torso, SPR said in an Oct. 19 news release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
